To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Departmental Publication (Transparency)
Home Office

Apr. 12 2024

Source Page: Non-technical summaries granted in 2024
Document: Non-technical summaries: projects granted in 2024, January to March (PDF)

Found: Mice are able to clear these bacteria quickly (in health), less quickly in vascular disease.

Departmental Publication (Transparency)
Ministry of Defence

Mar. 19 2024

Source Page: FOI responses published by MOD: week commencing 18 March 2024
Document: Joining the Royal Navy with spinal surgery for Scheuremann's disease (JSP 950) (PDF)

Found: Peripheral vascular diseases 10. Raynaud’s phenomenon or vasospastic disease.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 29 May 2023
Document: FOI 23/351 - attachment 1 (PDF)

Found: , Cerebral thrombosis, Cerebral vascular occlusion, Cerebral vasoconstriction, Cerebral venous thrombosis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 27 March 2023
Document: FOI 23/188 - attachment (PDF)

Found: associated with neurological disorders and peripheral vascular disease in the lower limbs.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: 2 Raynauds syndrome 2 Peripheral arterial occlusive disease 2 Peripheral venous disease (venous insufficiency

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/857 - attachment 2 (PDF)

Found: findings abnormal Gastrointestinal sounds abnormal 1 0 Colitis (excl infective) Crohn's disease

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: thrombosis and Ret inal vascular occl usion.

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 3 (PDF)

Found: VAERD Vaccine -associated enhanced respiratory disease VTE Venous thromboembolism VITT Vaccine

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 9 (PDF)

Found: the study data sources 3 11-Apr- 20239.3.2.1 Safety OutcomesTable 1, AESI ‘Thrombocytopenia with venous

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: deleted “thrombocytopenia, venous thromboembolism” from the list of AESIsThese three names refe r